{"DataElement":{"publicId":"2425470","version":"1","preferredName":"Patient International Breast Cancer Study Group Randomization Yes No Indicator","preferredDefinition":"the yes/no indicator whether a patient was randomized for a trial sponsored by the The International Breast Cancer Study Group (IBCSG), created as the 'Ludwig Breast Cancer Study Group' in 1977, is dedicated to innovative clinical research designed to improve the prognosis of women with breast cancer.","longName":"PT_RNDMIZ_IBCSG_IND2","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3534074","version":"1","preferredName":"Patient International Breast Cancer Study Group Randomization","preferredDefinition":"the randomization of a patient for a trial sponsored by the The International Breast Cancer Study Group (IBCSG), created as the 'Ludwig Breast Cancer Study Group' in 1977, is dedicated to innovative clinical research designed to improve the prognosis of women with breast cancer.","longName":"PT_IBSC_RNDM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2183985","version":"1","preferredName":"Patient","preferredDefinition":"Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.","longName":"Patient","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C0030705","definition":"Individuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB302B67-DEB0-1206-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-26","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3534072","version":"1","preferredName":"International Breast Cancer Study Group Randomization","preferredDefinition":"The International Breast Cancer Study Group (IBCSG), created as the 'Ludwig Breast Cancer Study Group' in 1977, is dedicated to innovative clinical research designed to improve the prognosis of women with breast cancer. Patients and investigators from six continents: Europe, Australia/ New Zealand, Africa, Asia, and North and South America, cooperate by participating in extensive clinical trials in the Adjuvant breast cancer setting. IBCSG has been a pioneer in research into combined hormonal therapy and chemotherapy, timing and duration of Adjuvant Therapies, and Quality of Life of breast cancer patients. (from ibcsg.org):The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.","longName":"C25530:C25196","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Breast Cancer Study Group","conceptCode":"C25530","definition":"A group dedicated to innovative clinical research designed to improve the prognosis of women with breast cancer. Patients and investigators from six continents: Europe, Australia/ New Zealand, Africa, Asia, and North and South America, cooperate by participating in extensive clinical trials in the Adjuvant breast cancer setting. IBCSG has been a pioneer in research into combined hormonal therapy and chemotherapy, timing and duration of Adjuvant Therapies, and Quality of Life of breast cancer patients. (from ibcsg.org)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Randomization","conceptCode":"C25196","definition":"The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C544CD67-9E8C-EFE7-E040-BB89AD4301C9","latestVersionIndicator":"Yes","beginDate":"2012-07-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-20","modifiedBy":"ONEDATA","dateModified":"2012-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C544CD67-9E9D-EFE7-E040-BB89AD4301C9","latestVersionIndicator":"Yes","beginDate":"2012-07-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-07-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Was the patient randomized to","type":"Preferred Question Text","description":"Was the patient randomized to Trial 26-02","url":null,"context":"CTEP"}],"origin":"IBCSG CRF:International Breast Cancer Study Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0498CADA-1FBB-1F0F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-11-02","modifiedBy":"CAMPBELB","dateModified":"2012-07-20","changeDescription":"Replaced VD IBCSG Ind-2 2421126v1 with VD ID#3506068 - Yes No Indicator   - dbw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}